<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02526199</url>
  </required_header>
  <id_info>
    <org_study_id>2014-005383-14</org_study_id>
    <nct_id>NCT02526199</nct_id>
  </id_info>
  <brief_title>Protracted Mixture of Local Anesthetics for Major Foot and Ankle Surgery</brief_title>
  <official_title>Protracted Mixture of Local Anesthetics for Major Foot and Ankle Surgery. A Randomized Double-blind, Controlled Study Comparing Bupivacaine-Epinephrine 0.5% Versus Bupivacaine-Epinephrine 0.5% With Dexamethasone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rasmus Wulff Hauritz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kolding Sygehus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To extend the duration of peripheral nerve blockade after major foot and ankle surgery the
      investigators randomize the postoperative treatment with either perineurial sciatic nerve
      blocks with 0.5% Bupivacaine-Epinephrine with or without Dexamethasone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Painfree period (time until first pain sensation in operated foot)</measure>
    <time_frame>48 hours</time_frame>
    <description>Patients are closely monitored in the PACU until first pain sensation in the operated foot.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain in the operated foot, measured on a numeric rating scale (0-10)</measure>
    <time_frame>Every 30 minuttes from the patient enters the PACU to the nerve block wears of</time_frame>
    <description>Pain score at rest, with the operated foot elevated on a pillow, ranging from 0 [no pain] to 10 [worst possible pain]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensibility score, measured with a hided tactile pinprick-sensation under the 3.rd toe on the operated foot</measure>
    <time_frame>Every 30 minutes from the patient enters the PACU to the sensations core reach 2</time_frame>
    <description>Sensitivy score measured on a 3 point scale 0 (no sensation) (impared sensation) 2 (full or normal sensation) compared to non-operated side</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total consumption of opioids during the length of stay</measure>
    <time_frame>48 hours</time_frame>
    <description>A cummulative calculation of equipotente doses of oral milligrams of morphin during the length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of sleep first night measured on a 3 point scale</measure>
    <time_frame>hours</time_frame>
    <description>Quality of sleep measured on the morning after operation. 0 (good sleep, no interruptions) by pain from operated foot) 1 (sleep, but interruption without pain) 2 (sleep but interrupted by pain from operated foot)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Group BA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine + Adrenaline Sciatic nerve block with Bupivacaine 0.5% + Epinephrine 5 microg/ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group BAD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bupivacine + Adrenaline + Dexamethasone Sciatic nerve block with Bupivacaine 0.5% + Epinephrine 5 microg/ml PLUS Dexamethsone 8 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Sciatic nerve block</description>
    <arm_group_label>Group BA</arm_group_label>
    <arm_group_label>Group BAD</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <description>Adjuvant to perinerual block</description>
    <arm_group_label>Group BA</arm_group_label>
    <arm_group_label>Group BAD</arm_group_label>
    <other_name>Adrenaline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Adjuvant to perinerual block</description>
    <arm_group_label>Group BAD</arm_group_label>
    <other_name>Deaxagalene</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 17

          -  scheduled major foot and ankle surgery

          -  written informed consent

          -  fertile women in anti conceptive treatment

          -  fertile women not in anti conceptive treatment, but with negative urin-HCG on day of
             surgery

        Exclusion Criteria:

          -  patients not able to understand or cooperate

          -  allergies to medicines involved

          -  daily buse of steroids

          -  daily use of opioids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesia, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <state>Region Midt</state>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2015</study_first_submitted>
  <study_first_submitted_qc>August 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2015</study_first_posted>
  <last_update_submitted>September 22, 2016</last_update_submitted>
  <last_update_submitted_qc>September 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Kolding Sygehus</investigator_affiliation>
    <investigator_full_name>Rasmus Wulff Hauritz</investigator_full_name>
    <investigator_title>Consultant Anesthesia</investigator_title>
  </responsible_party>
  <keyword>Local anesthetics</keyword>
  <keyword>Perineural nerve blocks</keyword>
  <keyword>Perineurial Dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

